Apollo (APO.US) reportedly plans to acquire Johnson & Johnson’s (JNJ.US) orthopedics business in a potential deal valued at nearly $20 billions
智通财经2026/09/12 03:16Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Apollo (APO.US) reportedly plans to acquire Johnson & Johnson (JNJ.US) orthopedics business, with a potential deal valued at nearly 20 billions USD.
Global alternative asset management firm Apollo Global Management is reportedly in talks to acquire Johnson & Johnson's orthopedics division, DePuy Synthes. The deal could value the business at nearly 20 billions USD.
Dell surges 12% in a single day to a record high, named by Oracle as a "core supplier" for 10 billion capital expenditure
Oracle's management specifically named Dell as a direct beneficiary supplier in the company's AI capital expenditure of $95 billions. In addition, RBC Capital initiated coverage with an "outperform" rating, with analysts highlighting Dell's strong moat in the AI infrastructure supply chain. Dell's share price surged 11.98% in a single day, reaching a record high, pushing its market capitalization past $360 billions, with a cumulative gain of nearly 350% so far this year.
Crypto prices
More
